INNL Innocoll Holdings plc

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Innocoll Holdings plc - INNL

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Innocoll Holdings plc (“Innocoll”) (NASDAQ:INNL) resulting from allegations that Innocoll may have issued materially misleading business information to the investing public.

Innocoll’s lead product candidate is XARACOLL, which aims to treat postsurgical pain. Innocoll filed a New Drug Application (“NDA”) with the U.S. Food & Drug Administration (“FDA”) in October 2016.

On December 29, 2016, Innocoll announced that it had received a Refusal to File letter from the FDA as to XARACOLL’s NDA. According to Innocoll, the reasons the FDA provided included, among other things, that XARACOLL should have been characterized as a drug/device combination, requiring Innocoll to submit further information. On this news, Innocoll shares fell $1.16 in intraday trading on December 30, or 66%.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Innocoll investors. If you purchased shares of Innocoll on or before December 29, 2016, please visit the firm’s website at http://www.rosenlegal.com/cases-1019.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

EN
30/12/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Innocoll Holdings plc

 PRESS RELEASE

Gurnet Point L.P. Completes Acquisition of Innocoll Holdings plc

CAMBRIDGE, Mass. & ATHLONE, Ireland--(BUSINESS WIRE)-- Gurnet Point L.P., a healthcare investment fund, and Innocoll Holdings plc (NASDAQ:INNL), a global pharmaceutical and medical device company, today announced that Gurnet Point has completed its acquisition of Innocoll. As a result, Innocoll’s shares (NASDAQ:INNL) will no longer be traded on the NASDAQ Global Select Market as of today. Under the terms of the agreement, Gurnet Point will acquire Innocoll for $1.75 per share in cash, and up to $4.90 in cash from a contingent value ...

 PRESS RELEASE

Gurnet Point L.P. enters into agreement to acquire Innocoll Holdings p...

CAMBRIDGE, Mass. & ATHLONE, Ireland--(BUSINESS WIRE)-- Gurnet Point L.P., a healthcare investment fund, and Innocoll Holdings plc (NASDAQ:INNL), a global pharmaceutical and medical device company, today announced that they have reached an agreement on the terms of a recommended offer. Under the recommended offer, Gurnet Point will acquire Innocoll for $1.75 per share in cash, and up to $4.90 in cash from a contingent value right (CVR), for a total potential per share value of up to $6.65 or up to approximately $209 million in aggregate. ...

 PRESS RELEASE

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Innocoll...

NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Innocoll Holdings plc (“Innocoll”) (NASDAQ: INNL) between March 17, 2016 and December 29, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania. To get more information go to: http://www.zlk.com/pslra/innocoll-holdings-plc or contact Joseph E. Lev...

 PRESS RELEASE

INNL INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investor...

NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania on behalf of investors who purchased Innocoll Holdings plc (NASDAQ:INNL) securities between March 17, 2016 and December 29, 2016. Click here to learn about the case: http://www.wongesq.com/pslra/innocoll-holdings-plc. There is no cost or obligation to you. According to the complaint, throughout the Class Period Defendants made false and/or misleading ...

 PRESS RELEASE

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Innocoll H...

NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Innocoll Holdings plc (“Innocoll”) (NASDAQ:INNL) between March 17, 2016 and December 29, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Eastern District of Pennsylvania. To get more information go to: http://www.zlk.com/pslra/innocoll-holdings-plc or contact Joseph E. Levi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch